CY2025 Q1
| Company | Value | End Date | SEC Filing |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | $344,000,000.00 | 2025-03-31 | View |
| 1st FRANKLIN FINANCIAL CORPORATION | $253,163,872.00 | 2025-03-31 | View |
| HUMANA INC | $410,000,000.00 | 2025-03-31 | View |
| PACKAGING CORP OF AMERICA | $71,300,000.00 | 2025-03-31 | View |
| Sysco Corporation | $114,000,000.00 | 2025-03-29 | View |
| Micron Technology, Inc. | $1,375,000,000.00 | 2025-02-27 | View |
| U S GLOBAL INVESTORS INC | $2,302,000.00 | 2025-03-31 | View |
| MITEK SYSTEMS, INC. | $16,211,000.00 | 2025-03-31 | View |
| Starbucks Corporation | $222,100,000.00 | 2025-03-30 | View |
| HCA Healthcare, Inc. | $550,000,000.00 | 2025-03-31 | View |
| IONIS PHARMACEUTICALS, INC. | $681,349,000.00 | 2025-03-31 | View |
| ASURE SOFTWARE, INC. | $62,189,000.00 | 2025-03-31 | View |
| VERICEL CORPORATION | $43,342,000.00 | 2025-03-31 | View |
| NEKTAR THERAPEUTICS | $2,019,000.00 | 2025-03-31 | View |
| Urban Outfitters, Inc. | $365,937,000.00 | 2025-04-30 | View |
| NEUROCRINE BIOSCIENCES, INC. | $815,300,000.00 | 2025-03-31 | View |
| ERIE INDEMNITY COMPANY | $1,047,540,000.00 | 2025-03-31 | View |
| Azenta, Inc. | $176,781,000.00 | 2025-03-31 | View |
| ASTROTECH Corp | $0.00 | 2025-03-31 | View |
| BioMarin Pharmaceutical Inc | $506,724,000.00 | 2025-03-31 | View |
| F5, INC. | $0.00 | 2025-03-31 | View |
| CYTOKINETICS, INCORPORATED | $150,687,000.00 | 2025-03-31 | View |
| Akamai Technologies, Inc | $0.00 | 2025-03-31 | View |
| DEXCOM, INC. | $236,800,000.00 | 2025-03-31 | View |
| NiSource Inc. | $81,200,000.00 | 2025-03-31 | View |
| Tapestry, Inc. | $0.00 | 2025-03-29 | View |
| GARMIN LTD | $1,226,464,000.00 | 2025-03-29 | View |
| LIQUIDMETAL TECHNOLOGIES INC | $9,108,000.00 | 2025-03-31 | View |
| ELEVANCE HEALTH, INC. | $1,060,000,000.00 | 2025-03-31 | View |
| CARDIFF ONCOLOGY, INC. | $12,714,000.00 | 2025-03-31 | View |
| LegalZoom.com, Inc. | $1,588,000.00 | 2025-03-31 | View |
| Turning Point Brands, Inc. | $5,724,000.00 | 2025-03-31 | View |
| PRECIGEN, INC. | $750,000.00 | 2025-03-31 | View |
| ANAPTYSBIO, INC | $43,021,000.00 | 2025-03-31 | View |
| ETSY, INC | $129,481,000.00 | 2025-03-31 | View |
| SERVICENOW, INC. | $4,335,000,000.00 | 2025-03-31 | View |
| HubSpot, Inc. | $176,557,000.00 | 2025-03-31 | View |
| Olo Inc. | $43,371,000.00 | 2025-03-31 | View |
| ZEVRA THERAPEUTICS, INC. | $6,091,000.00 | 2025-03-31 | View |
| AGIOS PHARMACEUTICALS, INC. | $531,253,000.00 | 2025-03-31 | View |
| CASTLE BIOSCIENCES, INC. | $5,570,000.00 | 2025-03-31 | View |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | $39,355,000.00 | 2025-03-31 | View |
| MACOM Technology Solutions Holdings, Inc. | $337,100,000.00 | 2025-04-04 | View |
| ULTRAGENYX PHARMACEUTICAL INC. | $68,563,000.00 | 2025-03-31 | View |
| Alkermes plc. | $32,044,000.00 | 2025-03-31 | View |
| Guidewire Software, Inc. | $323,305,000.00 | 2025-04-30 | View |
| Aclaris Therapeutics, Inc. | $85,211,000.00 | 2025-03-31 | View |
| Oscar Health, Inc. | $1,872,677,000.00 | 2025-03-31 | View |
| Acumen Pharmaceuticals, Inc. | $48,795,000.00 | 2025-03-31 | View |
| MARCUS & MILLICHAP, INC. | $61,113,000.00 | 2025-03-31 | View |
| SENTINELONE, INC | $412,662,000.00 | 2025-04-30 | View |
| Atea Pharmaceuticals, Inc. | $0.00 | 2025-03-31 | View |
| BLUEPRINT MEDICINES CORPORATION | $323,547,000.00 | 2025-03-31 | View |
| Inspire Medical Systems, Inc. | $44,831,000.00 | 2025-03-31 | View |
| Caribou Biosciences, Inc. | $3,987,000.00 | 2025-03-31 | View |
| Stoke Therapeutics, Inc. | $22,989,000.00 | 2025-03-31 | View |
| BABCOCK & WILCOX ENTERPRISES, INC. | $2,400,000.00 | 2025-03-31 | View |
| SNOWFLAKE INC. | $956,144,000.00 | 2025-04-30 | View |
| UroGen Pharma Ltd. | $4,514,000.00 | 2025-03-31 | View |
| FULGENT GENETICS, INC. | $494,111,000.00 | 2025-03-31 | View |
| Moderna, Inc. | $2,418,000,000.00 | 2025-03-31 | View |
| PRAXIS PRECISION MEDICINES, INC. | $144,032,000.00 | 2025-03-31 | View |
| Arcus Biosciences, Inc. | $8,000,000.00 | 2025-03-31 | View |
| SEER, INC. | $45,579,000.00 | 2025-03-31 | View |
| GOSSAMER BIO, INC. | $0.00 | 2025-03-31 | View |
| Allogene Therapeutics, Inc. | $55,506,000.00 | 2025-03-31 | View |
| Mirum Pharmaceuticals, Inc. | $20,912,000.00 | 2025-03-31 | View |
| CoreWeave, Inc. | $0.00 | 2025-03-31 | View |
| DOORDASH, INC. | $842,000,000.00 | 2025-03-31 | View |
| ORIC PHARMACEUTICALS, INC. | $20,039,000.00 | 2025-03-31 | View |
| CLOVER HEALTH INVESTMENTS, CORP. /DE | $216,506,000.00 | 2025-03-31 | View |
| Royalty Pharma plc | $219,000,000.00 | 2025-03-31 | View |
| NAUTILUS BIOTECHNOLOGY, INC. | $54,023,000.00 | 2025-03-31 | View |
| Orchestra BioMed Holdings, Inc. | $1,900,000.00 | 2025-03-31 | View |
| Abacus Global Management, Inc. | $2,743,338.00 | 2025-03-31 | View |
| KYMERA THERAPEUTICS, INC. | $312,335,000.00 | 2025-03-31 | View |
| TOURMALINE BIO, INC. | $26,000,000.00 | 2025-03-31 | View |
| ENERGY VAULT HOLDINGS, INC. | $0.00 | 2025-03-31 | View |
| NET Power Inc. | $10,051,000.00 | 2025-03-31 | View |
| CANTOR EQUITY PARTNERS, INC. | $103,062,623.00 | 2025-03-31 | View |
| AN2 Therapeutics, Inc. | $11,480,000.00 | 2025-03-31 | View |
| Pagaya Technologies Ltd. | $740,828,000.00 | 2025-03-31 | View |
| Silvaco Group, Inc. | $0.00 | 2025-03-31 | View |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Browse By Company
All SEC filings and reported GAAP facts from 2010 to now for every company
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations